Super Micro slides 8% after stock is dropped from Nasdaq 100
Super Micro Computer CEO Charles Liang at the Computex conference in Taipei, Taiwan, on June 5, 2024.Annabelle Chih | Bloomberg ...
Tag: Moderna Inc
Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
Robert F. Kennedy Jr. in Phoenix on Aug. 23, 2024.Thomas Machowicz | ReutersShares of vaccine makers fell Thursday as President-elect ...
Trump says he will give RFK Jr. a major health role if he wins the White House. Here’s what that means for patients, drugmakers
Republican presidential nominee, former U.S. President Donald Trump welcomes Robert F. Kennedy Jr. to the stage at a Turning Point ...
FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
A vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. Dado Ruvic | ReutersThe Food ...
U.S. will again offer free at-home Covid tests starting in late September
Images By Tang Ming Tung | DigitalVision | Getty ImagesThe Biden administration on Friday said it will resume offering free ...
The rise of OpenAI and Microsoft’s $13 billion bet on the AI startup
OpenAI, the company behind the ChatGPT chatbot, was founded in 2015 by a number of researchers, academics and entrepreneurs, including ...
Moderna stock falls 20% as it slashes guidance on low EU sales, tough U.S. vaccine market
The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty ImagesModerna on ...
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Kena Betancur | Corbis News | Getty ImagesPfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO ...
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Empty bottles of Moderna's Covid-19 vaccine.Fred Tanneau | AFP | Getty ImagesModerna on Monday said its combination vaccine that targets ...
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday ...
